INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $61,000 | -63.0% | 1,097 | -51.7% | 0.00% | -66.7% |
| Q1 2022 | $165,000 | +42.2% | 2,270 | +162.1% | 0.01% | +50.0% |
| Q3 2021 | $116,000 | +33.3% | 866 | -80.2% | 0.00% | -55.6% |
| Q3 2020 | $87,000 | +1640.0% | 4,371 | +1518.9% | 0.01% | +350.0% |
| Q1 2019 | $5,000 | +400.0% | 270 | +250.6% | 0.00% | – |
| Q4 2018 | $1,000 | -98.3% | 77 | -96.3% | 0.00% | -100.0% |
| Q3 2018 | $60,000 | +757.1% | 2,083 | +739.9% | 0.02% | +950.0% |
| Q2 2018 | $7,000 | -89.2% | 248 | -91.9% | 0.00% | -94.1% |
| Q1 2018 | $65,000 | – | 3,065 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |